title: Development of Basal Cell Carcinoma With Squamous Differentiation During Vismodegib Treatment.
authors.affiliation: Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.
authors.forename: Lawrence
authors.initials: L
authors.lastname: Feigenbaum
authors.forename: Brian L
authors.initials: BL
authors.lastname: Scott
authors.forename: Molly S
authors.initials: MS
authors.lastname: Moye
authors.forename: Rajiv I
authors.initials: RI
authors.lastname: Nijhawan
mesh_terms: D000284:Administration, Oral; D000369:Aged, 80 and over; D000813:Anilides / Q000008:administration & dosage / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000473:pathology*; D002454:Cell Differentiation; D019008:Drug Resistance, Neoplasm; D005153:Facial Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D005260:Female; D006801:Humans; D015580:Mohs Surgery; D009669:Nose Neoplasms / Q000473:pathology* / Q000601:surgery; D011725:Pyridines / Q000008:administration & dosage / Q000627:therapeutic use*; D013524:Surgical Flaps
chemical_list: D000813:Anilides; D000970:Antineoplastic Agents; C538724:HhAntag691; D011725:Pyridines